German Leisure Stock News

XTRA:EDL
XTRA:EDLEntertainment

3 Global Dividend Stocks Yielding Up To 7.7%

As global markets navigate through geopolitical tensions, rising oil prices, and shifting monetary policy expectations, investors are keenly focused on strategies that can provide stability and income. In this context, dividend stocks have become an attractive option for those looking to balance growth with regular income streams amidst market volatility.
XTRA:RWE
XTRA:RWERenewable Energy

How Renewable Power Deal Will Impact RWE Stock Investors

RWE has agreed a long-term power purchase deal to supply up to 75 GWh of renewable electricity each year to Air Products’ hydrogen facilities, including a new liquefaction plant in Rotterdam that is planned to be Europe’s largest liquid hydrogen site and to comply with EU RED III rules. The contract links RWE’s renewable generation directly to hydrogen production that qualifies as renewable fuel of non-biological origin, which can sharpen demand visibility for its clean power while tying the...
XTRA:ADS
XTRA:ADSLuxury

adidas (XTRA:ADS) Has The Market Watching, What Is Behind The Attention?

Adidas (XTRA:ADS) is back under scrutiny after a local Single Shoe advertising campaign featuring former Israeli soldier Shalev Biton drew criticism, sparked boycott calls, and prompted apologies from Adidas units in Israel and Arabia. At a share price of €146.45, adidas has seen the 1 month share price return fall 12.49% and the 3 month share price return decline 15.49%, while the 1 year total shareholder return is down 16.35%. This suggests recent sentiment has weakened even as headlines...
XTRA:DWS
XTRA:DWSCapital Markets

Is DWS Group GmbH KGaA (XTRA:DWS) Fully Priced On Its Deutsche Asset Management Rebrand?

DWS Group GmbH KGaA (XTRA:DWS) has set a clear marker for its future identity. The asset manager plans to rebrand globally as Deutsche Asset Management from November 2026, unifying operations under one banner. DWS Group GmbH KGaA shares trade at €77.1, with a 7 day share price return of 3.35% and a 90 day gain of 33.28%. This lines up with a strong 1 year total shareholder return of 56.59%, suggesting momentum has been building as the rebrand story has taken shape. Compare the rebrand-driven...
HMSE:BIO0
HMSE:BIO0Biotechs

Biotest GmbH KGaA (HMSE:BIO0) After Trimodulin Buzz Faces A Split Valuation View

Biotest GmbH KGaA (HMSE:BIO0) is back in focus after fresh industry commentary highlighted its Trimodulin candidate among emerging therapies in community-acquired bacterial pneumonia, drawing attention to the company’s role in this specific treatment niche. Set against the Trimodulin headlines, Biotest GmbH KGaA’s share price sits at €33.2 with a 90‑day share price return of 3.11% and year to date gain of 5.06%, while the 12.30% total shareholder return over one year points to gradually...
XTRA:DB1
XTRA:DB1Capital Markets

What Deutsche Börse Shares Fixed Income Offering Means For Shareholders

Deutsche Börse AG has completed a €600 million fixed to floating rate senior, subordinated, unsecured bond offering, with callable variable coupon notes maturing in September 2052. The 26 year fixed income deal extends Deutsche Börse’s funding profile and adds long dated, flexible interest cost to support its market infrastructure and data ambitions. With this €600 million fixed income issuance now in place, we can assess how the new long dated funding shapes Deutsche Börse's investment...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

How Positive Phase III Imaging Data Will Impact Bayer Stock Investors

Bayer reported detailed Phase III REVEAL data for its investigational PET radiotracer iodine 124 evuzamitide in cardiac amyloidosis, showing high sensitivity and specificity across AL and ATTR subtypes and a generally manageable safety profile in 170 evaluated adults. The compound already holds Breakthrough Therapy and Orphan Drug designations, so positive diagnostic accuracy data could strengthen Bayer’s late stage pipeline story in specialized cardiovascular imaging. We will now look at...
XTRA:IFX
XTRA:IFXSemiconductor

Is Infineon Technologies (XTRA:IFX) Stock Priced Right After An 85% Run?

Infineon Technologies has delivered an 85.0% return over the past three years, yet current checks suggest the stock now trades close to what a Discounted Cash Flow (DCF) based intrinsic value estimate would call fair rather than clearly cheap. The 85.0% gain over three years leaves existing holders sitting on strong headline returns, which raises the bar for fresh buyers looking for value. Infineon Technologies features as a key supplier in the growing avalanche breakdown diodes market that...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank (XTRA:DBK) Could Be 10% Above Fair Value As Inflation Risks Return

Deutsche Bank’s inflation warning as a fresh equity signal Deutsche Bank (XTRA:DBK) has put inflation risk back on the table. In its latest dislocations report, the lender argues that comfort around prices, rates and growth now rests on fragile assumptions. The report points to a squeeze from rising energy, food and commodity costs just as investors are pricing in steady conditions across bonds, equities and credit. That situation is the starting point for reassessing Deutsche Bank...
XTRA:CBK
XTRA:CBKBanks

How Capital Returns At Commerzbank Stock Have Changed Its Investment Story

Commerzbank has launched a tender offer for up to €750,000,000 of its outstanding Additional Tier 1 notes and recently completed a €997.91m fixed income issue, as part of a wider capital and funding reshuffle that began in late August 2026. The combination of the €1.2b share buyback, targeted AT1 repurchases and fresh senior funding shows Commerzbank actively reconfiguring its capital stack and interest cost profile rather than relying solely on future earnings growth. With Commerzbank using...
XTRA:SAP
XTRA:SAPSoftware

SAP (XTRA:SAP) Stock Still Looks Discounted After Its 62% Five Year Gain

SAP stock has delivered a solid 61.8% gain over the past 5 years, yet current valuation checks send a more cautious message, with the intrinsic value estimate pointing to meaningful upside while the share price has recently come under pressure. Recent drawdowns and a mixed overall value score leave SAP looking potentially cheap on some measures, but not an obvious across the board bargain. The 61.8% return over 5 years suggests SAP has rewarded patient holders, which makes any current...
XTRA:P911
XTRA:P911Auto

3% Below Fair Value As Porsche (XTRA:P911) Reworks Global Sales Structure

Sales reorganisation puts Porsche in focus Dr. Ing. h.c. F. Porsche (XTRA:P911) has moved to restructure its global Sales and Marketing division, consolidating sales regions and dissolving several central departments to push more responsibility into local markets. The plan reduces the current setup from five sales regions to four, folds Germany into a broader Europe hub, and combines North, Central and South America into a single Americas region under Porsche Cars North America chief Timo...
XTRA:OHB
XTRA:OHBAerospace & Defense

European Space Stocks Worth Watching After Isar Aerospace Reaches Orbit

Europe’s space ambitions just became more real. Isar Aerospace has reached orbit on its second test flight and reports a commercial pipeline above €10b, which underlines how much paying demand is forming around launch capacity. For investors, that kind of pressure on supply can reshape which stocks benefit from the new space race. This article reveals three stocks exposed to this news and explains why each could matter for your portfolio. The three stocks below are just a starting sample. The...
XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care (XTRA:FME) Could Be 8% Undervalued On FDA Warning Letter

The U.S. Food and Drug Administration issued a warning letter to Fresenius Medical Care (XTRA:FME) over significant quality control violations at its Ogden, Utah plant, raising fresh questions for investors about operational risk. At a share price of €39.22, Fresenius Medical Care has seen mixed momentum, with a 1-day share price return of 1.61% but a 30-day share price return that declined 6.73%. The 1-year total shareholder return declined 3.62%, while the 3-year total shareholder return...
XTRA:SAP
XTRA:SAPSoftware

SAP Stock And 2 AI Infrastructure Buyers Backed By Global Research Acquisitions

UK research labs keep producing world class ideas, yet many of the most promising spinouts still seek capital and buyers abroad. That drift of talent and IP can turn into a hunting ground for large overseas acquirers that are willing to pay for scale, patents and teams. This article looks at three stocks that are exposed to that trend and explains how each could benefit or face pressure as it evolves. These three stocks are just a starting sample, and the full screen surfaced 13 more large...
XTRA:PSAN
XTRA:PSANSoftware

3 European Automation Stocks Retail Investors Are Watching Closely

European industrials are under pressure as warnings of job cuts, tariff disputes and rising Chinese competition unsettle the outlook for factories across the region. Periods of stress can expose weak business models and put a spotlight on companies with stronger automation and productivity stories. This article looks at three European industrial automation and productivity leaders that appear most exposed to the latest EU China trade headlines and explains why these stocks may warrant closer...
XTRA:SIE
XTRA:SIEIndustrials

Does Siemens (XTRA:SIE) SMR Turbine Deal Hint At A Deeper Automation And Electrification Shift?

Siemens Energy recently secured a contract to build large steam turbines for Rolls-Royce’s small modular nuclear reactors at its Newcastle factory, reviving domestic turbine manufacturing in the UK and adding 550 jobs. This move links Siemens more closely to the UK’s emerging SMR nuclear supply chain, potentially deepening its role in future clean energy infrastructure projects. Next, we’ll explore how Siemens Energy’s new UK SMR turbine role may influence Siemens’ longer-term industrial...
XTRA:SIX2
XTRA:SIX2Transportation

Sixt (XTRA:SIX2) Expands At Dallas And Boise On Questions Over Whether The Stock Is Undervalued

Sixt stock: U.S. airport push puts Dallas and Boise in focus Sixt (XTRA:SIX2) is back on investor radars after Sixt USA added new airport locations at Dallas Love Field and Boise, extending its U.S. network to 58 sites and entering Idaho. Sixt’s latest U.S. airport additions come after a mixed period for the stock, with the share price at €72.15 and a year to date share price return of 1.91%, but a 1 year total shareholder return that declined 10.20% and a 5 year total shareholder return that...
XTRA:DEZ
XTRA:DEZMachinery

DEUTZ (XTRA:DEZ) Expands Engine Reach With Kirloskar, Is The Stock Still Undervalued?

DEUTZ (XTRA:DEZ) stock is back in focus after the company agreed a co operation with Kirloskar Oil Engines Limited to distribute compact under 2 litre engine solutions across Europe and North America. At a share price of €12.84, DEUTZ has seen strong momentum build over 2026, with a 30 day share price return of 24.54% and a year to date share price return of 48.35%. The 3 year total shareholder return of 231.77% reflects a much longer period of strong performance that this new engine co...
XTRA:A6T
XTRA:A6TElectronic

3 European Software Stocks Tied To AI Content Moderation Demand

With Brussels turning up the heat on social media over extremist and harmful content, trust and safety tools are moving from back office expense to front page issue. That shift could reshape which European software stocks absorb higher compliance costs and which help others manage them. This article walks through three stocks exposed to this news, explaining how their cloud based AI and moderation capabilities could matter for your portfolio. The three stocks below are just a starting sample,...
XTRA:TUI1
XTRA:TUI1Hospitality

What TUI (XTRA:TUI1)'s New TUI Blue Leadership Means For Shareholders

TUI Blue Hotel Betriebsgesellschaft recently appointed Louise Bates, previously Director of Brand & Products at TUI Hotels & Resorts, as Managing Director alongside Bernd Mäser, while long-time executive Artur Gerber departed the company but remained an adviser. This leadership change brings to the forefront Bates’s track record in shaping hotel concepts such as TUI Sensatori and TUI Sensimar and her close ties with international hotel partners, which could influence how TUI evolves its...
XTRA:CBK
XTRA:CBKBanks

Commerzbank (XTRA:CBK) Launches AT1 Tender As Its Valuation Looks Fully Valued

Commerzbank (XTRA:CBK) is back in focus after launching a tender offer for two Additional Tier 1 note issues and setting a €750 million maximum acceptance amount, together with a planned new AT1 issuance. Commerzbank shares have been firming, with a 1-day share price return of 1.11% adding to a 90-day share price return of 13.37%. The 1-year total shareholder return of 33.04% and a very large 5-year total shareholder return suggest that momentum has been building around recent capital actions...
XTRA:RDC
XTRA:RDCConsumer Retailing

Why Did Redcare Pharmacy (XTRA:RDC) Move Today?

Redcare Pharmacy (XTRA:RDC) is back in focus after the company announced that CEO Olaf Heinrich will step down after three years, including his role on the Managing Board. He will, however, remain available in an advisory capacity. The CEO transition comes at a time when Redcare Pharmacy’s share price has been volatile, with a 1 day share price return of 4.29% but a 7 day share price return down 6.22%. The 90 day share price return of 23.24% contrasts with a 1 year total shareholder return...
XTRA:ZAL
XTRA:ZALSpecialty Retail

Is Zalando (XTRA:ZAL) Below Fair Value After The Marks And Spencer ZEOS Deal?

Zalando (XTRA:ZAL) is back in focus after its ZEOS logistics network began handling Marks & Spencer’s entire online direct to consumer business across 22 European markets, reshaping how both groups approach fulfillment. Despite the Marks & Spencer deal putting Zalando’s logistics capabilities in the spotlight, the stock’s recent momentum has been soft. The 30 day share price return is down 3.88% and the 1 year total shareholder return is down 4.78% from a €23.51 share price today. Compare...